US Plasma Fractionation Market worth US$13.80 billion by 2028 with 6.4% CAGR | MarketsandMarkets™. [Yahoo! Finance]
ADMA Biologics Inc (ADMA)
Last adma biologics inc earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.admabiologics.com
Company Research
Source: Yahoo! Finance
US$10.13 billion in 2023, at a CAGR of 6.4% during the forecast period. The increasing use of immunoglobulins in a variety of therapeutic fields, as well as the market's players' strategic expansion of plasma collection centers and inventories, along with the rising incidence of respiratory diseases like alpha-1-antitrypsin deficiency (AATD) and Chronic obstructive pulmonary disease (COPD), are the main factors driving the market's expansion. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=93798284 Browse in-depth TOC on " US Plasma Fractionation Market 150 - Tables 47 - Figures 140- Pages By Based on Product, the US plasma fractionation market is segmented into protease inhibitors, coagulation factor concentrates, immunoglobulins, albumins, and other products. Immunoglobulins accounted for the largest share of the US plasma fractionation market in 2022. The dominance of this segment is mainly attributed to the rise in the cases of neurological a
Show less
Read more
Impact Snapshot
Event Time:
ADMA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADMA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADMA alerts
High impacting ADMA Biologics Inc news events
Weekly update
A roundup of the hottest topics
ADMA
News
- ADMA Biologics (NASDAQ:ADMA) had its "hold (c)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- 3 High Growth Tech Stocks To Watch In The US Market [Yahoo! Finance]Yahoo! Finance
- The Play On ADMA Biologics: A Discounted Stock With Good Prospects [Seeking Alpha]Seeking Alpha
- High Growth Tech Stocks In The US Market With Potential [Yahoo! Finance]Yahoo! Finance
- ADMA Biologics: Why The Dip To $16 Resets The Buy Case [Seeking Alpha]Seeking Alpha
ADMA
Earnings
- 11/5/25 - Miss
ADMA
Sec Filings
- 12/16/25 - Form 4
- 11/21/25 - Form 4
- 11/5/25 - Form 10-Q
- ADMA's page on the SEC website